Decision Algorithms for Direct Oral Anticoagulant Use in Patients With Nonvalvular Atrial Fibrillation: A Practical Guide for Neurologists

Isabella Canavero, Giuseppe Micieli, Maurizio Paciaroni

Research output: Contribution to journalArticlepeer-review

Abstract

Direct oral anticoagulants (DOACs) are valid alternative options to vitamin K antagonists due to their limited interactions with drugs or food and the fact that they do not require regular coagulation monitoring. To this regard, recent practice guidelines recommend that DOACs should be considered as first-line anticoagulant therapy for stroke prevention in patients with nonvalvular atrial fibrillation (NVAF). This review (1) outlines current international guidelines for the management of DOACs to prevent stroke in patients with NVAF, (2) outlines indications for elderly patients as well as specific settings including acute coronary syndromes and intracranial hemorrhage, and (3) offers a practical guide for the use of DOACs in neurological settings.

Original languageEnglish
Pages (from-to)396-404
Number of pages9
JournalClinical and Applied Thrombosis/Hemostasis
Volume24
Issue number3
DOIs
Publication statusPublished - Apr 1 2018

Keywords

  • direct oral anticoagulant
  • nonvalvular atrial fibrillation
  • stroke

ASJC Scopus subject areas

  • Hematology

Fingerprint Dive into the research topics of 'Decision Algorithms for Direct Oral Anticoagulant Use in Patients With Nonvalvular Atrial Fibrillation: A Practical Guide for Neurologists'. Together they form a unique fingerprint.

Cite this